Navigation Links
Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
Date:7/15/2008

- Company Reports Favorable Phase 1 RX-3341 Results -

NEW HAVEN, Conn., July 15 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced the initiation of a Phase 2 clinical trial for an intravenous form of antibiotic compound RX-3341 in the treatment of complicated skin and skin structure infections (cSSSIs). The safety and efficacy study will be conducted at 35 sites across the United States. As a precursor to this news the Company also announced positive results of a two-part Phase 1 study with the same candidate.

"We have made significant progress in advancing this next-generation broad spectrum antibiotic further toward clinical use," said Dr. Susan Froshauer, President and CEO of Rib-X. "We intend to rapidly move forward with the development of our IV dosage form to meet the need for a broad-spectrum antibiotic in the hospital setting, particularly one that is active against quinolone-resistant MRSA. We also hope to further progress our oral dosage form to ensure a greater diversity of use in the treatment of serious infections in a number of settings."

Phase 2 Study Design

This Phase 2 double-blind study (study RX-3341-201) will evaluate the safety and efficacy of RX-3341 at two different doses administered intravenously to hospitalized cSSSI patients every 12 hours for 5 to 14 days, as compared to tigecycline (Tygacil(TM)). The study's primary endpoint is the assessment of RX-3341 efficacy, safety and tolerability at the two different doses compared to that of tigecycline's standard dosing regimen. A secondary endpoint for the study is the assessment of clinical efficacy of RX-3341 compared to tigecycline in patients with cSSSIs caused by methicillin- resistant Staphylococcus aureus (MRSA).

Phase I Results

The two-part Phase 1 stud
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
2. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
3. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
4. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
5. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
6. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
7. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
8. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
9. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
10. Isis Pharmaceuticals Conference Call Notice
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... April 2015 Hospira, Inc. ... Entwicklung von Biosimilar-Behandlungen, sprach heute auf der jährlichen ... (EGA) in London über ... Verfügbarkeit von Biosimilars für Patienten. Das ... Papers mit dem Titel „Why extrapolation is ...
(Date:4/24/2015)... 2015  Perrigo Company plc ("Perrigo" or the "Company") ... unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL ... Perrigo for $60.00 per share in cash and 2.2 ... "Offer").  The Board previously concluded that ... the Company and its future growth prospects and was ...
(Date:4/24/2015)... HILL, N.C. , April 24, 2015 /PRNewswire/ ... the ability of consumers to educate themselves about ... expanded the tools and techniques available to market ... Given the changing consumer marketplace, it,s imperative that ... approaches to better identify market opportunities, niches and ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
... and WALTHAM, Mass., May 25, 2011 Interleukin Genetics, Inc. ... USP Hospitales now offers the innovative Heart Health Genetic ... Hospitales, the flagship hospital in Madrid, and will soon ... identifies single nucleotide variations in two Interleukin-1 (IL-1) genes ...
... retains Adapt IP Ventures to market XDATA,s intellectual ... breast cancer detection. Over many decades, XDATA has ... automatically capturing and combining ultrasound and X-ray mammography ... patents, leading companies and research hospitals including GE, ...
Cached Medicine Technology:USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 2USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 3USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 4XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System 2
(Date:4/26/2015)... April 26, 2015 Compare-autoinsurance.org has released a ... insurance quotes . , The easiest way to find low ... have access to the best offers online, in a simple ... different providers for information about auto insurance prices. All the ... web page. , It is now possible to compare ...
(Date:4/26/2015)... 2015 A live auction will be ... from hospitals, surgery centers and other medical facilities around ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and ... place Tuesday, April 28th starting at 10:00am EDT. The ... 5025 North Hiatus Rd., Sunrise, FL 33351. Anyone ...
(Date:4/26/2015)... April 26, 2015 Forbes Living ... city is one which is synonymous with clean beaches, sparkling ... and education are major economic influencers in the city on ... dynamic talk show are pleased to announce the show will ... 26 at 3:00 PM PDT. Tune in to find out ...
(Date:4/25/2015)... Portland, ME (PRWEB) April 26, 2015 ... a Canadian based integrative healthcare event. The Integrative ... taking place October 23-24, 2015 at the Sheraton ... Healthcare Symposium Canada is one of the most ... a clinically relevant, evidenced-based CME program. The event ...
(Date:4/25/2015)... April 25, 2015 In the United ... and above needed treatment for an illicit drug ... Substance Abuse and Mental Health Services Administration’s Survey on ... these alarming numbers are harrowing stories of men and ... abuse . David H. Kerr , founder and ...
Breaking Medicine News(10 mins):Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Integrative Healthcare Event launching in Canada 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
... international team of researchers led by the University of East ... aid the early detection and diagnosis of inflammatory bowel disease. ... microscope which allows clinicians to view the bacteria that are ... disease and ulcerative colitis. "Bacteria within the wall of ...
... Dec. 4 (HealthDay News) -- Advances in the treatment ... according to two studies scheduled to be presented at ... Fla. Results from one study suggest that treating ... while another group of researchers are scheduled to report ...
... Medical Intensive Care Unit (MICU) at Vanderbilt University Medical Center for ... H1N1 flu pandemic. The tall and burly Warren County, TN, ambulance ... down and hugged some of the nurses he recognized. ... it for the next 20 days. I am just so grateful ...
... , FRIDAY, Dec. 3 (HealthDay News) -- ... cancer fell after doctors starting receiving lower Medicare payments ... patients with metastatic prostate cancer stayed steady, a new ... in the Journal of the National Cancer Institute ...
... News) -- Education and rule enforcement reduce brain and ... equipment such as headgear and mouthguards does not lower ... came to that conclusion after analyzing previous studies of ... rugby players, including six that examined the use of ...
... HealthDay Reporter , FRIDAY, Dec. 3 (HealthDay News) -- While good-looking ... may be at a disadvantage, a new study from Israel suggests. ... as likely to generate requests for an interview, the study found. ... percent less likely to get a response, whether or not the ...
Cached Medicine News:Health News:Blood Cancer Advances May Improve Survival 2Health News:Blood Cancer Advances May Improve Survival 3Health News:Over-reactive immune system kills young adults during pandemic flu 2Health News:Over-reactive immune system kills young adults during pandemic flu 3Health News:Over-reactive immune system kills young adults during pandemic flu 4Health News:Medicare Cuts May Have Spurred Drop in Prostate Cancer Treatment 2Health News:Good Looks May Help Land the Interview -- for Men 2Health News:Good Looks May Help Land the Interview -- for Men 3
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
Double-ended. 10 mm sickle shaped blade. 27 mm blunt, curved double-edged blade....
Fixed smooth rod which slides on skin. Designated most popular model or size....
Medicine Products: